Breast Cancer Research and Treatment

Evidence for a Tumour Suppressive Function of APRG1 in Breast Cancer
pp. 97-100(4)
Authors: Leris, A.C.A.; Roberts, T.R.; Jiang, W.G.; Newbold, R.F.; Mokbel, K.

RhoC-GTPase is a Novel Tissue Biomarker Associated with Biologically Aggressive Carcinomas of the Breast
pp. 101-110(10)
Authors: Kleer, Celina; Griffith, Kent; Sabel, Michael; Gallagher, Gary; Golen, Kenneth; Wu, Zhi-Fen; Merajver, Sofia

The Presence of Serum Anti-p53 Antibodies from Patients with Invasive Ductal Carcinoma of Breast: Correlation to Other Clinical and Biological Parameters
pp. 111-115(5)
Authors: Gao, Rui-juan; Bao, Hui-zheng; Yang, Qiong; Cong, Qi; Song, Jin-na; Wang, Li

Timely Withdrawal of G-CSF Reduces the Occurrence of Thrombocytopenia During Dose-dense Chemotherapy
pp. 117-123(7)
Authors: Timmer-Bonte, J.N.H.; Mulder, P.H.M.; Peer, P.G.M.; Beex, L.V.A.M.; Tjan-Heijnen, V.C.G.

A Multicenter Randomized Clinical Trial Evaluating Interleukin-2 Activated Hematopoietic Stem Cell Transplantation and Post-transplant IL-2 for High Risk Breast Cancer Patients
pp. 125-134(10)
Authors: Isaacs, Claudine; Slack, Rebecca; Gehan, Edmund; Ballen, Karen; Boccia, Ralph; Areman, Ellen; Kramer, Ruthie; Hayes, Daniel; Herscowitz, Herbert; Lippman, Marc

The role of X-linked genes in breast cancer
pp. 135-143(9)
Authors: Thakur, Archana; Xu, Hiaming; Wang, Yong; Bollig, Aliccia; Biliran, Hector; Liao, Joshua

Incidence of Male Breast Cancer in California, 1988–2000: Racial/Ethnic Variation in 1759 Men
pp. 145-150(6)
Authors: O’Malley, Cynthia; Shema, Sarah; White, Edward; Glaser, Sally

Patterns of Local and Distant Disease Relapse in Patients with Breast Cancer Treated with Primary Chemotherapy: Do Patients with a Complete Pathological Response Differ from Those with Residual Tumour in the Breast?
pp. 151-158(8)
Authors: Chaturvedi, Shailesh; McLaren, Catherine; Schofield, Andrew; Ogston, Keith; Sarkar, Tarun; Hutcheon, Andrew; Miller, Iain; Heys, Steven

Multiple Signaling Pathways are Activated During Insulin-like Growth Factor-I (IGF-I) Stimulated Breast Cancer Cell Migration
pp. 159-168(10)
Authors: Zhang, Xihong; Lin, Min; Golen, Kenneth; Yoshioka, Kiyoko; Itoh, Kazuyuki; Yee, Douglas

Innate Anti-breast Cancer Immunity of Apoptosis-resistant Human -T cells
pp. 169-175(7)
Authors: Guo, Ben; Liu, Zhiyong; Aldrich, Wayne; Lopez, Richard

Inhibition of Either Phosphatidylinositol 3-kinase/Akt or the Mitogen/Extracellular-regulated Kinase, MEK/ERK, Signaling Pathways Suppress Growth of Breast Cancer Cell Lines, but MEK/ERK Signaling is Critical for Cell Survival
pp. 177-188(12)
Authors: Ripple, Maureen; Kalmadi, Sahana; Eastman, Alan